A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Procalamine Indications, Dosage, Storage, Stability - Amino Acid and Glycerin
Procalamine Indications, Dosage, Storage, Stability - Amino Acid and Glycerin
INDICATIONS AND USAGE
ProcalAmine is indicated for peripheral administration in adults
to preserve body protein and improve nitrogen balance in well-nourished, mildly
catabolic patients who require short-term parenteral nutrition.
DOSAGE AND ADMINISTRATION
ProcalAmine is a convenient source of nonprotein calories to
preserve lean body mass, amino acids, maintenance electrolytes, and water for
adult patients.
Determination of nitrogen balance and accurate daily body weights
(corrected for fluid balance) are probably the best means of assessing individual
protein requirements.
Approximately three liters per day of ProcalAmine will provide
a total of 90 grams of amino acids, 390 nonprotein calories and the recommended
daily intake of principal intra- and extracellular electrolytes for the stable
patient. Therapy can begin with three liters of ProcalAmine on the first day
with close monitoring of the patient.
As with all intravenous fluid therapy, the goal is to provide
adequate water to compensate for insensible, urinary and other losses, and electrolytes
for replacement and maintenance. These requirements should be determined frequently
and appropriately administered.
Additional electrolytes should be administered evenly throughout
the day, and irritating medications should be injected at an alternate infusion
site.
Pediatric Use
ProcalAmine is intended for use in adults. Use of ProcalAmine
in pediatric patients is governed by the same considerations that affect the
use of any amino acid solution in pediatrics. The amount administered is dosed
on the basis of grams of amino acids/kg of body weight/day. Two to three g/kg
of body weight for infants with adequate calories are generally sufficient to
satisfy protein needs and promote positive nitrogen balance. Solutions administered
by peripheral vein should not exceed twice normal serum osmolarity (718 mOsmol/L).
Venous irritation at an infusion site can be minimized by the
selection of a large peripheral vein as well as by slowing the rate of infusion.
In pediatric patients, the final solution should not exceed twice normal serum
osmolarity (718 mOsmol/L).
Parenteral drug products should be inspected visually for particulate
matter and discoloration, prior to administration, whenever solution and container
permit.
HOW SUPPLIED
ProcalAmine® (3% Amino Acid and 3% Glycerin Injection with
Electrolytes) is supplied sterile and nonpyrogenic in 1000 mL intravenous infusion
bottles, packaged six per case.
|
NDC
|
Cat. No.
|
Size
|
|
ProcalAmine (3% Amino Acid and 3% Glycerin Injection
with Electrolytes)
|
|
0264-1915-07
|
S9050 (Solid Stopper)
|
1000 mL
|
|
0264-1915-00
|
S9150 (Air Tube)
|
1000 mL
|
Exposure of pharmaceutical products to heat should be minimized.
Avoid excessive heat. Protect from freezing. It is recommended that the product
be stored at room temperature (25°C); however, brief exposure up to 40°C does
not adversely affect the product. Protect from light until use.
Revised: May 2003
ProcalAmine is a registered trademark of B.
Braun Medical Inc.
Made in USA
top
